- Nov. 8, 2019
-- The global point-of-care diagnostics market (https://www.psmarketresearch.com/
market) is witnessing growth, due to miniaturization of point-of-care testing devices, technological advancement of point-of-care devices, and healthcare decentralization. Based on product, the glucose monitoring kits segment is the largest contributor to the global point-of-care diagnostics market, due to increasing prevalence of lifestyle associated diseases, such as diabetes; whereas, the cardiac markers and infectious diseases segments are expected to grow at the fastest rate in the coming years.
The massive unexplored point-of-care diagnostics market in the emerging economies is creating ample opportunities for the growth of the global point-of-care diagnostics market, in the coming years. The advanced research and development activities and new product developments by the major players are supporting the demand of point-of-care devices, with better and cost effective point-of-care diagnostics, thus fuelling the growth of the global point-of-care diagnostics market.Read more: https://www.psmarketresearch.com/market-analysis/point-of-care-diagnostics-market
Geographically, North America leads the global point-of-care diagnostics market, due to increasing lifestyle associated disease and increasing usage of point-of-care devices. Asia-Pacific is the fastest growing region in the global point-of-care diagnostics market, which is driven by growing healthcare expenditure, large pool of patients, increasing government initiatives and support. Moreover, the Asia-Pacific point-of-care diagnostics market is growing rapidly, due to growing research and development activities, and increasing funding towards development of point-of-care diagnostic products in the emerging economies, such as India and China.
The key players operating in the global point-of-care diagnostics market are Abbott Laboratories Inc., Siemens Healthcare, F Hoffmann La-Roche, Nipro Diagnostics Inc., Johnson & Johnson, Abaxis Inc., Alere Inc., Becton, Dickinson and Company, Beckman Coulter Inc., and Bayer Healthcare.